The global intra-abdominal pressure measurement devices market is expected to reach a valuation of US$ 98.9 million in 2023 and further expand at a CAGR of 12.40% during the forecast period, totaling around US$ 318.3 million by 2033.
The increasing prevalence of intra-abdominal hypertension and abdominal compartment syndrome drives market demand for intra-abdominal pressure measurement devices.
Patients in intensive care units (ICUs) all over the world frequently suffer from abdominal compartment syndrome (ACS) and intra-abdominal hypertension (IAH). The risk of ACS and IAH is evaluated using the intra-abdominal pressure measurement device. It is a key reason fuelling the intra-abdominal pressure measurement devices market growth.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rise in Intra-abdominal Hypertension and Advancement in Intra-abdominal Pressure Measuring Devices to Bolster Market Growth
Because intra-abdominal hypertension is becoming more common among patients in intensive care units worldwide, the demand for intra-abdominal pressure monitoring devices is projected to rise over the forecast period.
Nowadays, digital intra-abdominal pressure monitoring devices are often used in the ICU to constantly monitor patients who do not need doctors to monitor them. Hence, the digitalization of intra-abdominal pressure monitoring devices is estimated to boost the growth of the intra-abdominal pressure measurement devices market.
Similarly, the demand for compartment syndrome measurement devices is anticipated to grow shortly due to the growing availability and use of innovative instruments such as digital pressure monitors.
In addition, rising ICU admissions due to traumatic injuries and the increasing prevalence of chronic diseases in developing nations are key factors promoting market expansion.
The high risk of complications associated with intra-abdominal pressure measuring procedures is a key factor restraining the market's growth.
The bladder is often used to monitor intra-abdominal pressure in patients. Bladder infections and needle stick wounds are two significant issues with pressure management devices that could put patients at risk and cause discomfort.
Complicated surgical procedures may result in an elevation of the locations, and adhesion may produce false results regarding the patient's conditions, hindering the market growth for intra-abdominal pressure measurement devices. There are issues regarding the infusion volume, indications, measurement frequency, and zero-reference point while monitoring the patient. Such conditions are anticipated to impede market expansion.
Attributes | Details |
---|---|
Market CAGR (2023 to 2033) | 12.40% |
Market Valuation (2023) | US$ 98.9 million |
Market Valuation (2033) | US$ 318.3 million |
The global sales of intra-abdominal pressure management devices are projected to rise at an impressive CAGR of 12.40% between 2023 and 2033, compared to a 10.6% CAGR registered from 2018 to 2022. The market secured a valuation of US$ 54 million in 2018 and US$ 89.4 million in 2022.
In critically ill patients, abdominal compartment syndrome (ACS) and intra-abdominal hypertension (IAH) are recognized causes of morbidity and mortality. As a result, monitoring and measuring them becomes essential. For this purpose, intra-abdominal pressure measurement devices are being used.
Intra-abdominal pressure variations can occur in various medical situations, including hepatorenal syndrome, large-volume resuscitation, acute decompensated heart failure, and acute and sepsis pancreatitis, among several other indications.
Globally, there is rising concern over the prevalence of intra-abdominal hypertension (IAH). The escalating prevalence of IAH and ACS cases in both established and developing countries has also encouraged the introduction of technologically advanced devices into the market for intra-abdominal pressure measurement, which is estimated to boost market sales during the forecast period.
Since intra-abdominal hypertension is more common in critically ill patients, all patients in the ICU should have their intra-abdominal pressure monitored during the first few days. It has led to an upsurge in global sales of devices that monitor intra-abdominal pressure.
IAH and ACS in children are more likely to happen in cases of intra-peritoneal ascites, severe gut edema, and key fluid resuscitation. As a result, there is an increased demand for intra-abdominal pressure measurement devices for monitoring children, and this aspect is estimated to further support the market expansion for these devices throughout the upcoming years.
Demand to Remain High for Disposables in the Market
Based on product, the disposables segment held a substantial share of around 89.8% in the global market in 2023. It is projected to expand at a CAGR of about 12.5% throughout the forecast period. It can be attributed to the rising application of disposable devices for real-time intra-abdominal pressure monitoring.
Disposable monitoring tools establish a clinically accurate monitoring system that is standardized, effective, and safe. Measurements may be taken with this tool in just a few minutes. Thus, disposable products' rapid and effective utilization for measuring intra-abdominal pressure is estimated to fuel market growth through increased adoption over the forecast years.
Adoption Remains High for Measuring Intra-abdominal Hypertension
By application, the intra-abdominal hypertension segment held the highest market share of about 86.5% in the global market in 2023. It is further expected to accelerate at a CAGR of 12.7% from 2023 to 2033.
The high market share of this segment is due to the rising prevalence of intra-abdominal hypertension and the increasing usage of intra-abdominal pressure measurement devices for measuring IAH.
Intensive care unit (ICU) patients may suffer from intra-abdominal hypertension (IAH), which is becoming more widely recognized as a potential complication. IAH impacts all body systems, although the respiratory, nervous, cardiovascular, and renal systems are likely to be affected.
The Majority of Sales is to Remain Concentrated in Hospitals
The hospital segment held a higher market share value of around 73.7% in 2023, likely generating huge revenues during the forecast period. It can be attributed to the high prevalence of disease, advanced medical equipment, and the availability of skilled professionals.
Similarly, rising patient inclination towards opting for hospital treatments to reduce overall costs is estimated to generate demand for intra-abdominal pressure measurement devices across hospitals.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Countries | Forecast Value Share Between 2023 to 2033 |
---|---|
United States | 45.1% |
Germany | 6.7% |
Japan | 6.4% |
Countries | Forecast CAGR Between 2023 to 2033 |
---|---|
China | 16.0% |
India | 18.40% |
Australia | 15.70% |
United Kingdom | 11.40% |
Rapid Expansion of Healthcare Infrastructure To Boost Market Growth in the United States
As per FMI, the United States held around 45.1% share in the global market with a CAGR of 10.5% during the forecast period.
The rapid rise in hospitals and ambulatory surgical centers, the adoption of advanced medical technologies, and the surge in cases of chronic diseases are some key factors driving growth in the United States market.
According to the American Hospital Association (AHA), the total count of hospitals in the United States reached 6,093 in 2020, and this number is further expected to surge during the forthcoming years.
Similarly, growth in blunt abdominal trauma cases due to road accidents and increasing investments in research and development activities are expected to push the demand for intra-abdominal pressure measurement devices.
In addition, rising government initiatives and the heavy presence of leading manufacturers are estimated to support the expansion of the industry in the United States during the forthcoming years.
Easy Availability of Products at Much Lower Prices Fuelling Demand in China's Market
With around 40.8% share with a CAGR of 16.0%, China is significantly driving the global market during the forecast period.
Factors such as the rising prevalence of chronic disease, availability of medical devices at much lower prices, and surge in the export of medical devices are some key factors driving China's market.
Players in the global market have recently relied on Chinese suppliers to supply key equipment components. By offering items at relatively lower rates, these Chinese players are putting further pressure on their Western competitors to lower the pricing of their components and products.
Furthermore, Chinese key players supply raw materials, which are used for manufacturing intra-abdominal pressure measurement devices, at a lower cost, and this factor is estimated to boost the market expansion over the projected years.
Rise in Medical Tourism to Boost Sales in the United Kingdom Market
The United Kingdom held around 21.1% of the global market in 2023. It is projected to grow robustly during the next ten years, making it one of the most likely lucrative markets across Europe. The United States is estimated to register a CAGR of 11.40% in the global market by 2033.
The increasing risk of injuries in the geriatric population, the high prevalence of chronic diseases, and flourishing medical tourism are some factors driving the United Kingdom's intra-abdominal pressure measurement devices market.
Similarly, improvements in treatment protocols, demand for better diagnostics, and the preference for preventative abdominal decompression treatments for trauma management are estimated to all have a favorable effect on the country's market.
The market is highly fragmented, with several competitors in the intra-abdominal pressure measurement devices space. These companies are implementing mergers and acquisitions, partnerships and collaborations, and new product launches to meet consumer demand and expand their customer base.
Other Prominent Players in the Global Market are:
Instances of key developmental strategies by the industry players in the global market are given below:
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | US$ billion for Value |
Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
Key Segments Covered | Product, Application, End User, Region |
Key Companies Profiled | C.R. Bard, Inc.; ConvaTec Group PLC; Stryker Corporation; Biometrix Ltd. (Degania Silicone, Ltd.); Centurion Medical Products; Holtech Medical; ConvaTec Group PLC; Potrero Medical; Gaeltec Devises Ltd.; Speigelberg GmbH & Co. KG.; C2Dx Inc.; Scranton Gillette Communication; Nutrimedics S.A.; SEM Mthembu Medical (Pty) Ltd; Carl Zeiss AG |
Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
The intra-abdominal pressure measurement devices market is predicted to expand at a 12.40% CAGR through 2033.
The hospital sector drives the intra-abdominal pressure measurement devices market.
The intra-abdominal pressure measurement devices market is expected to surpass US$ 318.3 million by 2033.
The intra-abdominal pressure measurement devices market is anticipated to be US$ 98.9 million in 2023.
The United States is dominating the global intra-abdominal pressure measurement devices market by 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033 5.3.1. Disposables 5.3.2. Equipment 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Intra-abdominal Hypertension 6.3.2. Intra-compartment Pressure 6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033 7.3.1. Hospitals 7.3.2. Clinics 7.3.3. Trauma Centers 7.3.4. Ambulatory Surgical Centers (ASCs) 7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. U.K. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Product 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product 14.2.3. By Application 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Application 14.3.4. By End User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product 15.2.3. By Application 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Application 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. U.S. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product 16.1.2.2. By Application 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product 16.2.2.2. By Application 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product 16.3.2.2. By Application 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product 16.4.2.2. By Application 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product 16.5.2.2. By Application 16.5.2.3. By End User 16.6. U.K. 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product 16.6.2.2. By Application 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product 16.7.2.2. By Application 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product 16.8.2.2. By Application 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product 16.9.2.2. By Application 16.9.2.3. By End User 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product 16.10.2.2. By Application 16.10.2.3. By End User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product 16.11.2.2. By Application 16.11.2.3. By End User 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product 16.12.2.2. By Application 16.12.2.3. By End User 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product 16.13.2.2. By Application 16.13.2.3. By End User 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product 16.14.2.2. By Application 16.14.2.3. By End User 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product 16.15.2.2. By Application 16.15.2.3. By End User 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product 16.16.2.2. By Application 16.16.2.3. By End User 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product 16.17.2.2. By Application 16.17.2.3. By End User 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product 16.18.2.2. By Application 16.18.2.3. By End User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product 16.19.2.2. By Application 16.19.2.3. By End User 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product 16.20.2.2. By Application 16.20.2.3. By End User 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product 16.21.2.2. By Application 16.21.2.3. By End User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Product 16.22.2.2. By Application 16.22.2.3. By End User 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Product 16.23.2.2. By Application 16.23.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product 17.3.3. By Application 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. C.R. Bard, Inc. 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. ConvaTec Group PLC 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Stryker Corporation 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Biometrix Ltd. (Degania Silicone, Ltd.) 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Centurion Medical Products 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Holtech Medical 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. ConvaTec Group PLC 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Potrero Medical 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Gaeltec Devises Ltd. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Speigelberg GmbH & Co. KG. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 18.1.11. C2Dx Inc. 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.11.5.2. Product Strategy 18.1.11.5.3. Channel Strategy 18.1.12. Scranton Gillette Communication 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.12.5.2. Product Strategy 18.1.12.5.3. Channel Strategy 18.1.13. Nutrimedics S.A. 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.13.5.2. Product Strategy 18.1.13.5.3. Channel Strategy 18.1.14. SEM Mthembu Medical (Pty) Ltd 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 18.1.14.5.2. Product Strategy 18.1.14.5.3. Channel Strategy 18.1.15. Carl Zeiss AG 18.1.15.1. Overview 18.1.15.2. Product Portfolio 18.1.15.3. Profitability by Market Segments 18.1.15.4. Sales Footprint 18.1.15.5. Strategy Overview 18.1.15.5.1. Marketing Strategy 18.1.15.5.2. Product Strategy 18.1.15.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports